[Blood coagulation factors in patients with obstructive jaundice].
D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D000991:Antithrombins / Q000032:analysis; D001219:Aspartate Aminotransferases / Q000097:blood; D001650:Bile Duct Neoplasms / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001779:Blood Coagulation Factors / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D002761:Cholangitis / Q000097:blood; D002769:Cholelithiasis / Q000097:blood; D002779:Cholestasis / Q000097:blood* / Q000201:enzymology; D005165:Factor V / Q000032:analysis; D005167:Factor VII / Q000032:analysis; D005706:Gallbladder Neoplasms / Q000097:blood; D006801:Humans; D007501:Iron / Q000097:blood; D010190:Pancreatic Neoplasms / Q000097:blood; D011516:Prothrombin / Q000032:analysis
D000991:Antithrombins; D001779:Blood Coagulation Factors; D001798:Blood Proteins; D005165:Factor V; D005167:Factor VII; D011516:Prothrombin; D007501:Iron; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin
Zum Verhalten der Blutgerinnungsfaktoren bei Patienten mit Verschlussikterus